Alexion posts results of Phase 3 ravulizumab trial in HSCT-TMA
The study enrolled 148 participants and completed primary data collection on September 19, 2025. Results were first posted on ClinicalTrials.gov on November 4, 2026.
Primary source
ClinicalTrials.gov results record, November 4, 2026
Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant
Read the source: Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant clinicaltrials.gov
Machine-summarized from the source above; not independently reported. How we use automation